Clinical Trials on Unresectable Pancreatic Neuroendocrine Tumor in Belgium
Total 207 results
-
Lexicon PharmaceuticalsCompletedCarcinoid SyndromeUnited States, Australia, Belgium, Canada, France, Germany, Israel, Spain, Sweden, United Kingdom, Netherlands
-
Novartis PharmaceuticalsTerminatedSolid Tumors for Phase Ib | Pancreatic Cancer for Phase II | Colorectal Cancer for Phase IIUnited States, Canada, Australia, Belgium, Germany, Netherlands, Spain
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerCanada, Korea, Republic of, Taiwan, United States, Italy, United Kingdom, Thailand, Russian Federation, India, Belgium, Australia, Poland, Spain, Japan, Brazil, Czechia, Netherlands
-
Boehringer IngelheimRecruitingSmall Cell Lung Carcinoma | Neuroendocrine NeoplasmsUnited States, Belgium, Spain, Korea, Republic of, United Kingdom, Germany, Japan, China, Taiwan, France, Portugal, Bulgaria
-
Agenus Inc.SuspendedAdvanced MelanomaUnited States, Spain, United Kingdom, France, Germany, Switzerland, Belgium, Italy, Brazil, Russian Federation
-
Bristol-Myers SquibbTerminatedMalignant MelanomaGermany, United States, Mexico, Denmark, France, Belgium, United Kingdom, Spain
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Germany, Singapore, Italy, Australia, Netherlands, Sweden, Spain, Canada, Switzerland, Argentina, Brazil, China
-
European Organisation for Research and Treatment...TerminatedMetastatic Cancer | Melanoma (Skin)France, Norway, Belgium, Netherlands, United Kingdom, Austria, Czech Republic, Germany, Italy, Portugal, Switzerland
-
Bristol-Myers SquibbCompletedMelanomaSouth Africa, United States, Spain, France, Italy, Belgium, Austria, Israel, Germany, Norway, Canada, Brazil, Poland, Denmark, Czech Republic, Russian Federation, Ukraine, Argentina
-
Lexicon PharmaceuticalsCompletedCarcinoid SyndromeUnited States, Australia, Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Canada, Israel
-
Hoffmann-La RocheCompletedMalignant MelanomaItaly, United Kingdom, Belgium, Poland, Netherlands, Germany, Austria, Czechia, Ireland, Sweden
-
Bristol-Myers SquibbMedarexCompletedMelanomaFrance, United States, Australia, Belgium, Germany, South Africa, Canada, Brazil, Czech Republic, Hungary
-
Bristol-Myers SquibbCompletedMelanomaAustralia, France, Italy, Poland, United Kingdom, United States, Spain, Belgium, Denmark, Germany, Norway, Switzerland, Argentina, Austria, Sweden, Czechia, Hungary, Netherlands, Mexico, Canada, Israel, South Africa
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Mesothelioma | Advanced Solid Tumor | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Urothelial Carcinoma | Merkel Cell Carcinoma | HepatoCellular Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1)France, United States, Japan, Belgium, Australia
-
European Organisation for Research and Treatment...CompletedSarcoma | Breast Cancer | Head and Neck Cancer | Ovarian Cancer | Endometrial Cancer | Melanoma (Skin)Belgium
-
AstraZenecaActive, not recruitingMelanomaFrance, Germany, Italy, Spain, Belgium, Canada, Poland, Korea, Republic of, United Kingdom, United States, Australia
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)Italy, France, Spain, Switzerland, United Kingdom, Belgium, Australia, Norway, Poland, Finland, Netherlands, Germany, Israel, Denmark, Serbia, Estonia, Portugal, Russian Federation
-
Nouscom SRLActive, not recruitingMelanoma (Skin) | Non-Small-Cell Lung CarcinomaBelgium, Spain, United Kingdom
-
AmgenCompletedUnresected Stage IIIb to IVM1c MelanomaFrance, Poland, Italy, Russian Federation, Netherlands, Spain, United States, Austria, Belgium, United Kingdom, Germany, Hungary, Greece
-
Bristol-Myers SquibbCompletedMelanomaAustralia, France, Italy, Belgium, Finland, Austria, Ireland, Sweden, Switzerland, United Kingdom, Germany, Norway
-
Bristol-Myers SquibbWithdrawnMelanomaFrance, Italy, Poland, United States, Brazil, Spain, Australia, Denmark, Germany, Austria, Netherlands, Russian Federation, Belgium, United Kingdom, Sweden, Switzerland
-
European Organisation for Research and Treatment...CompletedDifferentiated Thyroid Cancer (DTC) | Medullary Thyroid Cancer (MTC)France, Belgium, Denmark, Italy, Netherlands, Germany, Poland, Spain, United Kingdom
-
Day One Biopharmaceuticals, Inc.RecruitingMelanoma | Colorectal Cancer | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | Thyroid Cancer, Papillary | Pilocytic Astrocytoma | Bladder Urothelial Carcinoma | Non-Small Cell Adenocarcinoma | MEK Mutation | RAS Mutation | Pancreatic Acinar Carcinoma | RAF Mutation | CRAF Gene Amplification | RAF1 Gene Amplification and other conditionsUnited States, Canada, Korea, Republic of, Spain, Australia, Belgium, France
-
ImaginAb, Inc.RecruitingMelanoma | Renal Cell Carcinoma | Non Small Cell Lung Cancer | Merkel Cell Carcinoma, UnspecifiedUnited States, Australia, Belgium, Netherlands, Switzerland, United Kingdom
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)France, Spain, United Kingdom, Belgium, Australia, Poland, Germany, Netherlands, Slovenia, Italy, Switzerland, Israel, Bulgaria, Croatia, Czech Republic, Estonia, Portugal, Turkey
-
Bristol-Myers SquibbCompletedMelanomaGermany, Italy, Sweden, United Kingdom, Belgium, Netherlands, Spain, Finland, Austria, Ireland, Poland, Portugal, Russian Federation, Switzerland, Czechia, Greece, Hungary, Luxembourg, Norway, Romania
-
GlaxoSmithKlineCompletedMelanomaUnited States, Italy, United Kingdom, France, Sweden, Germany, Poland, Australia, Belgium, Austria, Canada, Czechia, Greece, Russian Federation, Ukraine, Norway, Switzerland, New Zealand, Argentina
-
Novartis PharmaceuticalsTerminatedIn Escalation: All Patients With Solid Tumors and Lymphoma | In Expansion: Melanoma, Non-small Cell Lung CancerUnited States, Italy, Taiwan, Belgium, Spain, Germany, Japan
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Advanced Solid Tumors | Mesothelioma | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Merkel Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Anal Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1) | Urothelial... and other conditionsFinland, United States, United Kingdom, Belgium, Sweden, Denmark, Norway
-
Eli Lilly and CompanyTerminatedMelanomaUnited States, Italy, Australia, Spain, France, Netherlands, United Kingdom, Austria, Poland, Germany, Belgium, Taiwan, Canada, Finland, Israel, Korea, Republic of, Norway, Sweden
-
AmgenMerck Sharp & Dohme LLCTerminatedMelanomaUnited States, Finland, France, Germany, Italy, Canada, Czechia, Poland, Switzerland, Korea, Republic of, Russian Federation, United Kingdom, Australia, Netherlands, Spain, Austria, Belgium, Hungary, Portugal, Greece, South Africa
-
Bristol-Myers SquibbCompletedMelanomaBelgium, Brazil, United States, Canada, Spain, Greece, France, United Kingdom, Australia, Italy, Austria, Switzerland, Germany, Israel, Russian Federation, Romania, Czechia, Poland, New Zealand
-
AstraZenecaCompletedMelanomaUnited States, Italy, Spain, Sweden, Belgium, Canada, Poland, Switzerland, France, Russian Federation, United Kingdom, Australia, Argentina, Germany, Netherlands, Israel, South Africa, Austria, Greece, Mexico, Slovakia
-
Bristol-Myers SquibbActive, not recruitingMelanomaItaly, United States, Germany, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Denmark, Finland, France, Greece, Israel, Mexico, New Zealand, Norway, Poland, Romania, Russian Federation, Spain, Sweden, United Kingdom
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedMelanomaUnited States, France, Italy, United Kingdom, Spain, Belgium, Israel, Mexico, Japan, Canada, Netherlands, Sweden, Korea, Republic of, Australia, Russian Federation, Chile, Germany, Poland, Ireland, New Zealand, Denmark, Switzerland, South Africa
-
Bristol-Myers SquibbMedarexCompletedMelanomaUnited States, Brazil, France, Italy, South Africa, United Kingdom, Argentina, Australia, Canada, Ireland, Israel, Russian Federation, Spain, Belgium, Germany, Portugal, Chile, Austria, Poland, Netherlands, Ukraine, Czech Republic, ... and more
-
Bristol-Myers SquibbNektar TherapeuticsCompletedMelanomaCanada, Australia, France, Italy, Brazil, United States, Argentina, Austria, Belgium, Chile, Czechia, Finland, Germany, Greece, Ireland, Israel, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Spain, Sweden and more
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Canada, Spain, United Kingdom, Netherlands, Argentina, Australia, Austria, Brazil, Czechia, Denmark, France, Germany, Greece, Israel, Italy, Japan, New Zealand, Norway, Poland, Russian Federation, Sweden, Switz... and more
-
European Organisation for Research and Treatment...NCIC Clinical Trials GroupUnknownUlcerated MelanomasFrance, Denmark, Italy, Belgium, Spain, United Kingdom, Netherlands, Austria, Germany, Poland, Switzerland, Portugal
-
Pierre Fabre MedicamentEuropean Organisation for Research and Treatment of Cancer - EORTCActive, not recruitingMelanomaSpain, Canada, Hungary, Italy, Belgium, Netherlands, Australia, Czechia, Greece, Brazil, Portugal, Serbia, Sweden, Norway, Germany, Argentina, Romania, Poland, United Kingdom, Austria, Switzerland, France, South Africa
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, United Kingdom, Austria, Belgium, Hungary, Canada, Netherlands, Argentina, Australia, Brazil, Czechia, Denmark, France, Germany, Israel, Italy, Norway, Poland, Russian Federation, Spain, Switzerland, Taiwan, Korea, Republic... and more
-
Bristol-Myers SquibbActive, not recruitingMelanomaUnited States, Italy, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Mexico, Norway, Romania, Spain, Sweden, Switzerland, United Kingdom
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)France, Switzerland, Netherlands, Poland, Finland, Belgium, United Kingdom, Austria, Germany, Italy, Israel, Slovakia, Spain, Serbia, Portugal, Russian Federation, Bulgaria, Croatia, Turkey, Estonia, Sweden
-
GlaxoSmithKlineTerminatedMelanomaUnited States, Australia, Spain, Taiwan, Bulgaria, Estonia, Germany, Belgium, France, Sweden, Israel, Poland, Italy, Czechia, Switzerland, Korea, Republic of, Ireland, Canada, Argentina, Netherlands, Russian Federation, Ukraine, Aus... and more
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
KU LeuvenUnknownMelanoma | Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer | ALLBelgium
-
Novartis PharmaceuticalsActive, not recruitingMelanomaItaly, Belgium, Germany, Argentina, Australia, France, Israel, Netherlands, Switzerland, United States, United Kingdom, Norway
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
AstraZenecaCompletedUveal Melanoma | MetastaticUnited States, Czech Republic, Spain, United Kingdom, Germany, Canada, Israel, Netherlands, Belgium, France, Finland
-
Genzyme, a Sanofi CompanyActive, not recruitingMedullary Thyroid Cancer | Locally Advanced or Metastatic Medullary Thyroid CancerAustralia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czechia, Denmark, Finland, Germany, Greece, India, Israel, Italy, Korea, Republic of, Poland, Russian Federation, Sweden, United Kingdom